Preview

CHILDREN INFECTIONS

Advanced search

Lymphadenitis in children and adolescents: cause for oncologic suspicion?

https://doi.org/10.22627/2072-8107-2025-24-2-29-33

Abstract

Objective: to analyze the causes and clinical course of lymphadenitis in children and adolescents for timely detection of cases of malignant lymphadenopathy.

Materials and Methods: A clinical observational study of 268 patients diagnosed with lymphadenitis was conducted between January 2019 and December 2023.

Results: Lymphadenitis was the most frequent (56.5%) form of lymphadenopathy of unspecified cause at the time of the first medical examination. The structure was composed of: infectious diseases, including tuberculosis lesions (30.6%), herpesviral infections (5.6%), cat scratch disease (1.9%), urogenital (1.9%), dental and otorhinolangiologic pathologies (1.9%). Lymphadenitis of unspecified etiology accounted for 56.0% of cases in which symptoms regressed on empirical therapy. Isolated tuberculous lesions of peripheral lymph nodes were rare (1.1%). The median age was 8.0 (5;12) years, lymphadenopathy was detected more often in children 4—11 years old, the ratio of boys:girls was 1:1.4. The time from symptom onset to treatment was 5 days. Cervical and inguinal lymph nodes were most often affected (48.3%), dense or dense-elastic (89.1%) and painful (87.3%), the median size of lymph nodes was 2.0 (1.3; 3.0) centimeters. According to the ultrasound data, the lymph nodes was most often marked by decreased echogenicity (88,9%), heterogeneous echo structure (71,9%), with increased or normal blood flow (100,0%), presence of preserved lymph nodes capsule. Antibacterial therapy was administered to the majority of patients (83.3%). No improvement was observed in 27 patients (17.4% of patients receiving antibiotic therapy) who received repeated courses. 

About the Authors

G. M. Sergienko
Kuzbass Children's Clinical Hospital named after Prof. Y.E. Malakhovsky
Russian Federation

Novokuznetsk



M. M. Kotovich
Kuzbass Children's Clinical Hospital named after Prof. Y.E. Malakhovsky; Novokuznetsk State Institute for Advanced Training of Physicians — branch of FGBOU DPO RMANPO of the Ministry of Health of Russia
Russian Federation

Novokuznetsk



References

1. Pasternack M.S. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier, Inc; 2020.

2. Mariani R.A., Courville E.L. Reactive Lymphadenopathy in the Pediatric Population with a Focus on Potential Mimics of Lymphoma. Semin. Diagn. Pathol. 2023; 40(6):371—378. https://doi.org/10.1053/j.semdp.2023.05.004

3. Naumova A.S., Tiganova O.A., Ilyenko L.I. Differential diagnosis of lymphadenopathies in children. Pediatriya. Consilium Medicum. 2019; 2. (in Russ.)

4. Elmore S.A. Histopathology of the Lymph Nodes. Toxicol. Pathol. 2006; 34(5):425—454. https://doi.org/10.1080/01926230600964722

5. Kalinina N.M., Drygina L.B., Goreyko T.V. Modern ideas about the immunopathogenesis of infection caused by Epstein-Barr virus. Infection and Immunity. 2011;2. (in Russ.)

6. Rawat A., Bhattad S., Singh S. Chronic Granulomatous Disease. Indian J. Pediatr. 2016; 83(4):345—353. https://doi.org/10.1007/s12098-016-2040-3

7. Bozlak S., Varkal M.A., Yildiz I., et al. Cervical lymphadenopathies in children: a prospective clinical cohort study. Int. J. Pediatr. Otorhinolaryngol. 2016; 82:81—87. https://doi.org/10.1016/j.ijporl.2016.01.002

8. Celenk F., Gulsen S., Baysal E., et al. Predictive factors for malignancy in patients with persistent cervical lymphadenopathy. Eur. Arch. Otorhinolaryngol. 2016; 273:251—256. https://doi.org/10.1007/s00405-015-3717-3

9. Kharlamova F.S., Uchaikin V.F., Egorova N.Yu., Trunov V.O., Sulavko Ya.P. On the Differential Diagnosis Lymphadenopathy in Children. Detskie Infektsii=Children's Infections. 2013; 12(2). (in Russ.)

10. Mishin K.I., Naltov A.A. Lymphadenopathies in children: differential diagnosis. Academic Journal of Western Siberia. 2019; 5(82). (in Russ.)

11. Chang S.S.Y., Xiong M., How C.H., Lee D.M. An approach to cervical lymphadenopathy in children. Singapore Med. J. 2020; 61(11):569—577. https://doi.org/10.11622/smedj.2020151

12. Pecora F., Abate L., Scavone S., et al. Management of Infectious Lymphadenitis in Children. Children. 2021; 8(10):860. ttps://doi.org/10.3390/children8100860

13. Ataş E., Kesik V., Fidancı M.K., Kısmet E., Köseoğlu V. Evaluation of children with lymphadenopathy. Turk Pediatri Ars. 2014; 49(1):30—35. https://doi.org/10.5152/tpa.2014.847

14. Tsvetkova M.M., Gorkina Y.R., Dmitrenko K.A. Age peculiarities of the etiology of lymphadenopathy in children and adolescents. Modern Problems of Science and Education. 2019;3. (in Russ.)

15. Gaddey H.L., Riegel A.M. Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am. Fam. Physician. 2016; 94(11):896—903.


Review

For citations:


Sergienko G.M., Kotovich M.M. Lymphadenitis in children and adolescents: cause for oncologic suspicion? CHILDREN INFECTIONS. 2025;24(2):29-33. (In Russ.) https://doi.org/10.22627/2072-8107-2025-24-2-29-33

Views: 16


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-8107 (Print)
ISSN 2618-8139 (Online)